Investor directory
Braavos
Braavos seeks to partner with early-stage companies in diverse sectors, leveraging their expertise to foster growth.
The facts
- Typical cheque
- €100k – €10M
- Headquarters
- London, United Kingdom
- Founded
- 2019
Portfolio
CHARM TherapeuticsBarinthus Biotherapeutics (NAS: BRNS)First LightOsler DiagnosticsWild BiosciencePQShieldOxford IonicsSalience LabsOxCCUSpyBiotechLiving Optics
Does Braavos fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Braavos? Tell us what to correct and we will update it — or ask us to remove the entry.